-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Advances in inflammatory bowel diseases 2012
Abdo M Saad, Stacy A Kahn, Michele Rubin, David T Rubin
Conference Report: Clinical Investigation
-
Advances in inflammatory bowel diseases 2012
Abdo M Saad, Stacy A Kahn, Michele Rubin, David T Rubin
Conference Report: Clinical Investigation
-
Advances in inflammatory bowel diseases 2012
Abdo M Saad, Stacy A Kahn, Michele Rubin, David T Rubin
Conference Report: Clinical Investigation
-
Advances in inflammatory bowel diseases 2012
Abdo M Saad, Stacy A Kahn, Michele Rubin, David T Rubin
Conference Report: Clinical Investigation
-
Advances in inflammatory bowel diseases 2012
Abdo M Saad, Stacy A Kahn, Michele Rubin, David T Rubin
Conference Report: Clinical Investigation
-
Advances in inflammatory bowel diseases 2012
Abdo M Saad, Stacy A Kahn, Michele Rubin, David T Rubin
Conference Report: Clinical Investigation
-
Advances in inflammatory bowel diseases 2012
Abdo M Saad, Stacy A Kahn, Michele Rubin, David T Rubin
Conference Report: Clinical Investigation
-
Advances in inflammatory bowel diseases 2012
Abdo M Saad, Stacy A Kahn, Michele Rubin, David T Rubin
Conference Report: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation